News

Spineart is delighted to announce that 73 patients have been included, thus completing the enrollment of the BAGUERA® L study!

BAGUERA® L is a prosthesis intended as a replacement for a lumbar intervertebral disc, in patients with symptomatic lumbar disc disease. The patients were treated with BAGUERA® L from 2013 to 2018 in France and Germany. This study is monitoring the long-term safety and performance of BAGUERA® L.

We look forward to the results of this study and would like to thank Dr. Pedram from the Centre Aquitain du dos (France), Dr. Janata from the Grenzland MVZ (Germany), as well as their clinical teams, for their involvement and dedication to this clinical study and for reaching this milestone!

 Here are a few words from them on the BAGUERA® L:

“BAGUERA® L is a reliable implant for total disc replacement with very good long-term results. The instruments are user friendly and allow exact placement of the implant at the disc space.” commented Dr. Janata.

“BAGUERA® L combines ease of installation, MRI compatibility and the ability to choose a mobile or fixed core according to anatomical conditions.” said Dr. Pedram.

Spineart is delighted to announce that the TRYPTIK®2 C-Plate study has been recently completed with 42 patients enrolled!

These patients were treated with TRYPTIK®2 C-Plate Anterior Cervical Plate System between 2018 and 2020 in Spain, and retrospective/prospective data were collected to at least 1 year post surgery as per standard practice, to support the clinical safety, performance, and benefit of our device. 

We would like to thank Dr. Garcia from the Hospital Clínico Universitario de Valencia, as well as his team, for their involvement and dedication to this clinical study.

Dr. Garcia on the TRYPTIK®2 C-Plate: “TRYPTIK®2 C-Plate is easy to use and ensure a very good stability”.

Spineart is proud to announce the official full launch of its new Minimally Invasive Spine Surgery (MISS) System PERLA® TL MIS.

Built on a successful limited release period, the new MIS system is ready for use worldwide.

At Spineart, as an expert in Spine surgery, we strive to support all innovations that may support the transformation of spine surgery. While MISS appears in the literature as an approach resulting in less tissue trauma, less patient morbidity, and quicker recovery compared with conventional techniques, it has not yet been uniformly adopted globally by spine surgeons. The barriers to adoption may vary, and today with PERLA® TL MIS, Spineart is launching a system designed to simplify and to ease the instrumentation handling during surgery.

PERLA® TL MIS features many novelties designed for smooth procedures, optimizing OR time and allowing the system use in a wide variety of MISS cases.

In line with our tradition of simplicity in its purest senses, the system comes with only 2 sets of smart instruments featuring a secured and guided rod insertion. Designed with the company’s commitment to Quality, Innovation and Simplicity in mind, the PERLA® TL MIS screw offers:

• Extended Tabs and Built-in reduction, enabling OR time optimization
• 6 Cutting edges screw tips for a soft and precise insertion

PERLA® TL MIS benefits from the same attention to details, design and features as the PERLA®, Spineart’s most recent Posterior Fixation platform.

The launch of PERLA® TL MIS demonstrates our continuous commitment to transform spine surgery for the surgeons, patients and hospitals.

More information here.

Spine surgeons from California, Arizona and Texas gathered this past weekend in Scottsdale, Arizona, USA for the Spine Summit West.  The participants, a mix of orthopaedic and neurosurgical experts, all brought an impressive level of training and experience, and engaged in discussions centered on treatment options for the most complex cervical and lumbar disorders.  

We’re so grateful to our chairman, Dr Craig Kuhns from Austin Spine, for sharing his extensive knowledge and guiding the interactions, as well as our participants who all so genuinely care about education for the betterment of patients’ outcomes.    

This week, Spineart received the Prix de l’Économie Genevoise awarded by the CCIG – Chambre de commerce, d’industrie et des services de Genève and the Republic of Geneva.

We are honored by this award that distinguishes the most dynamic and promising mid-size company in the state every year. It’s a recognition of our employees’ and partners’ hard work in designing and marketing systems that transform spine surgery for patients worldwide. It also inspires us to pursue further innovations.

We send our congratulations to all the nominated companies and would like to thank the members of the Jury, the CCIG and its partners.

Spineart is proud to announce the launch of its upgraded, and now single-use, TEKTONA®2 Vertebral Fracture Reduction System, featuring enhanced ergonomics and usability.

Aligned with the company’s goal of transforming spine surgery for patients, surgeons, and hospitals; Spineart has developed a minimally invasive technology that enables a targeted, controlled, and multidirectional reduction of the vertebral compression fracture with a fully repositionable instrument.

Combined with TEKTONA® HV Cement, TEKTONA®2 preserves the trabecular structure, while enabling a precise and efficient treatment of the fracture.

 To learn more about this differentiated technology, please visit (link to product page).

TEKTONA®2 is not FDA Approved.

More information here